ALINA: efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK plus non-small cell lung cancer (NSCLC)

被引：0

作者：

Shah, Rajiv ^{[1
,2
]}

Solomon, Benjamin J. ^{[3
]}

Ahn, Jin Seok ^{[4
]}

Dziadziuszko, Rafal ^{[5
,6
]}

Barlesi, Fabrice ^{[7
]}

Nishio, Makoto ^{[8
]}

Lee, Dae Ho ^{[9
]}

Lee, Jong-Seok ^{[10
]}

Zhong, Wenzhao ^{[11
]}

Horinouchi, Hidehito ^{[12
]}

Mao, Weimin ^{[13
]}

Hochmair, Maximilian ^{[14
]}

de Marinis, Filippo ^{[15
]}

Migliorino, Maria Rita ^{[16
]}

Bondarenko, Igor ^{[17
]}

Lohmann, Tania Ochi ^{[18
]}

Xu, Tingting ^{[19
]}

Cardona, Andres ^{[20
]}

Bordogna, Walter ^{[21
]}

Ruf, Thorsten ^{[22
]}

Wu, Yi-Long ^{[11
]}

机构：

[1] Heidelberg Univ Hosp, Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany

[2] NCT Heidelberg, Translat Lung Res Ctr Heidelberg TLRC H, Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[3] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Australia

[4] Samsung Med Ctr, Dept Hematol & Oncol, Seoul, South Korea

[5] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland

[6] Med Univ Gdansk, Early Phase Clin Trials Ctr, Gdansk, Poland

[7] Saclay Univ, Dept Med Oncol, Int Ctr Thorac Canc CICT, Gustave Roussy,Fac Med, Le Kremlin Bicetre, France

[8] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan

[9] Asan Med Ctr, Dept Oncol, Seoul, South Korea

[10] Seoul Natl Univ, Div Hematol & Med Oncol, Dept Internal Med, Bundang Hosp, Seongnam, South Korea

[11] Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangzhou, Peoples R China

[12] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[13] Chinese Acad Sci, Inst Basic Med & Canc, Hangzhou, Zhejiang, Peoples R China

[14] Klin Floridsdorf, Dept Resp & Crit Care Med, Karl Landsteiner Inst Lung Res & Pulm Oncol, Vienna, Austria

[15] European Inst Oncol IRCSS, Thorac Oncol Div, Milan, Italy

[16] San Camillo Forlanini Hosp, Pneumooncol Unit, Rome, Italy

[17] Dnipropetrovsk Med Acad, Oncol & Med Radiol Dept, Dnipro, Ukraine

[18] F Hoffmann La Roche Ltd, PD Oncol, Basel, Switzerland

[19] Roche China Holding Ltd, Dept Clin Sci, Shanghai, Peoples R China

[20] F Hoffmann La Roche Ltd, Data & Stat Sci, Basel, Switzerland

[21] F Hoffmann La Roche Ltd, Prod Dev Med Affairs, Basel, Switzerland

[22] F Hoffmann La Roche Ltd, PD Safety Risk Management, Basel, Switzerland

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1018

引用

页码：243 / 244

页数：2

共 50 条

[31] Proton therapy for early-stage non-small cell lung cancer (NSCLC)
Gomez, Daniel R.
Li, Heng
Chang, Joe Y.
TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (02) : 199 - 204
[32] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
Shukla, Nikhil
Hanna, Nasser
LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 51 - 60
[33] Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions
Saw, Stephanie P. L.
Ang, Mei-Kim
Tan, Daniel S. W.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (12) : 1721 - 1731
[34] Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions
Stephanie PL Saw
Mei-Kim Ang
Daniel SW Tan
Current Treatment Options in Oncology, 2022, 23 : 1721 - 1731
[35] INDIRECT TREATMENT COMPARISON OF ALECTINIB VS. BRIGATINIB IN ALK plus NON-SMALL CELL LUNG CANCER (NSCLC)
Wong, W.
Sheinson, D.
VALUE IN HEALTH, 2019, 22 : S59 - S59
[36] Retrospective analysis of clinical outcomes of early stage ALK-positive (ALK plus ) non-small cell lung cancer (NSCLC).
Dagogo-Jack, Ibiayi
Santini, Fernando
Eng, Juliana
Yeap, Beow Y.
Izar, Benjamin
Chin, Emily
Litvak, Anya
Jones, David Randolph
Kris, Mark G.
Shaw, Alice Tsang
Gainor, Justin F.
Chaft, Jamie E.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[37] Impact and Safety of Adjuvant Chemotherapy on Pulmonary Function in Early Stage Non-Small Cell Lung Cancer
Kreuter, Michael
Vansteenkiste, Johan
Herth, Felix J. F.
Fischer, Juergen R.
Eberhardt, Wilfried
Zuna, Ivan
Reinmuth, Niels
Griesinger, Frank
Thomas, Michael
RESPIRATION, 2014, 87 (03) : 204 - 210
[38] Adjuvant Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Preoperative Chemotherapy
Deng, L.
Jiang, C.
Perimbeti, S.
Chen, H.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S234 - S234
[39] Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab
Yi, John S.
Ready, Neal
Healy, Patrick
Dumbauld, Chelsae
Osborne, Robyn
Berry, Mark
Shoemaker, Debra
Clarke, Jeffrey
Crawford, Jeffrey
Tong, Betty
Harpole, David
D'Amico, Thomas A.
McSherry, Frances
Dunphy, Frank
McCall, Shannon J.
Christensen, Jared D.
Wang, Xiaofei
Weinhold, Kent J.
CLINICAL CANCER RESEARCH, 2017, 23 (24) : 7474 - 7482
[40] Adjuvant Chemotherapy for Patients with Stage IB Non-Small Cell Lung Cancer
Wang, Jia
Yue, Yang
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S641 - S642

← 1 2 3 4 5 →